Concepedia

Emily Lin

EL

Statistics

Publications

9

Citations

284

H-Index

9

Active since

1994

Affiliations

Neurocrine Biosciences (United States)(Current)

Almirall (Spain)

Emily Lin is an author at Neurocrine Biosciences (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1994–2010

9

Publications

9

2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub>Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents

Deborah H. Slee, Yongsheng Chen, Xiaohu Zhang et al. · Journal of Medicinal Chemistry · 2008 · 43 citations · Full text

, , +15

Identification of Novel, Water-Soluble, 2-Amino-<i>N</i>-pyrimidin-4-yl Acetamides as A<sub>2A</sub>Receptor Antagonists with In Vivo Efficacy

Deborah H. Slee, Xiaohu Zhang, M. N. Moorjani et al. · Journal of Medicinal Chemistry · 2008 · 41 citations · Full text

, , +17

Neuroendocrine effects of light therapy in late luteal phase dysphoric disorder

Barbara L. Parry, Richard L. Hauger, Emily Lin et al. · Biological Psychiatry · 1994 · 39 citations

, , +12

Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A<sub>2A</sub>Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease

Xiaohu Zhang, John E. Tellew, Zhiyong Luo et al. · Journal of Medicinal Chemistry · 2008 · 38 citations · Full text

, , +17

Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties

John E. Tellew, Marion Lanier, M. N. Moorjani et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 34 citations · Full text

, , +5

1–5 of 9